DIMETHYL SULFOXIDE Drug Patent Profile
✉ Email this page to a colleague
When do Dimethyl Sulfoxide patents expire, and when can generic versions of Dimethyl Sulfoxide launch?
Dimethyl Sulfoxide is a drug marketed by Mylan Institutional and is included in one NDA.
The generic ingredient in DIMETHYL SULFOXIDE is dimethyl sulfoxide. There are seventy-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dimethyl sulfoxide profile page.
Summary for DIMETHYL SULFOXIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 302 |
| Clinical Trials: | 33 |
| Patent Applications: | 4,949 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DIMETHYL SULFOXIDE at DailyMed |
Recent Clinical Trials for DIMETHYL SULFOXIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rehab Werida | N/A |
| EmeraMed | Phase 2/Phase 3 |
| Clínica De La Costa Ltda. | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for DIMETHYL SULFOXIDE
Anatomical Therapeutic Chemical (ATC) Classes for DIMETHYL SULFOXIDE
US Patents and Regulatory Information for DIMETHYL SULFOXIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Institutional | DIMETHYL SULFOXIDE | dimethyl sulfoxide | SOLUTION;INTRAVESICAL | 076185-001 | Nov 29, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
